AGENUS INC Capital Expenditures Incurred but Not yet Paid
AGENUS INC (AGEN) reported Capital Expenditures Incurred but Not yet Paid of $4.76 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2024-08-08.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2025-03-17
- AGENUS INC capital expenditures incurred but not yet paid for the quarter ending 2023-06-30 was $869.00K.
- AGENUS INC capital expenditures incurred but not yet paid for the quarter ending 2023-03-31 was $3.89M, a 68.18% decline year-over-year.
- AGENUS INC capital expenditures incurred but not yet paid for the quarter ending 2022-12-31 was -$3.97M, a 310.73% decline year-over-year.
- AGENUS INC capital expenditures incurred but not yet paid for the quarter ending 2022-09-30 was -$2.01M, a 186.52% decline year-over-year.
- AGENUS INC capital expenditures incurred but not yet paid for fiscal 2022 was $4.58M, a 14.60% decline from fiscal 2021.
- AGENUS INC capital expenditures incurred but not yet paid for fiscal 2021 was $5.36M, a 1755.71% increase from fiscal 2020.
- AGENUS INC capital expenditures incurred but not yet paid for fiscal 2020 was $289.00K, a 76.73% decline from fiscal 2019.
- AGENUS INC capital expenditures incurred but not yet paid for fiscal 2019 was $1.24M, a 314.00% increase from fiscal 2018.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 3 month as first filed | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 6 month as first filed | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 9 month as first filed | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $869.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $4.76M 10-Q · filed 2024-08-08 | $796.00K derived: sum of 3 quarters · filed 2025-03-17 | -$1.21M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | $3.89M 10-Q · filed 2024-05-07 | -$73.00K derived: sum of 2 quarters · filed 2025-03-17 | -$2.08M derived: sum of 3 quarters · filed 2025-03-17 | -$3.76M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | -$3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$5.97M derived: sum of 2 quarters · filed 2025-03-17 | -$7.66M derived: sum of 3 quarters · filed 2025-03-17 | $4.58M 10-K · filed 2025-03-17 | ||||
| 2022-09-30 | -$2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$3.69M derived: sum of 2 quarters · filed 2023-11-09 | $8.55M 10-Q · filed 2023-11-09 | $10.43M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-06-30 | -$1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $10.55M 10-Q · filed 2023-08-08 | $12.44M derived: sum of 3 quarters · filed 2024-03-14 | $14.76M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-03-31 | $12.24M 10-Q · filed 2023-05-09 | $14.12M derived: sum of 2 quarters · filed 2024-03-14 | $16.44M derived: sum of 3 quarters · filed 2024-03-14 | $16.61M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2021-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $4.20M derived: sum of 2 quarters · filed 2024-03-14 | $4.37M derived: sum of 3 quarters · filed 2024-03-14 | $5.36M 10-K · filed 2024-03-14 | ||||
| 2021-09-30 | $2.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.49M derived: sum of 2 quarters · filed 2022-11-08 | $3.48M 10-Q · filed 2022-11-08 | $3.60M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-06-30 | $168.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.16M 10-Q · filed 2022-08-09 | $1.28M derived: sum of 3 quarters · filed 2023-03-16 | $786.00K derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | $991.00K 10-Q · filed 2022-05-10 | $1.11M derived: sum of 2 quarters · filed 2023-03-16 | $618.00K derived: sum of 3 quarters · filed 2023-03-16 | $1.03M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$373.00K derived: sum of 2 quarters · filed 2023-03-16 | $43.00K derived: sum of 3 quarters · filed 2023-03-16 | $289.00K 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | -$496.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$80.00K derived: sum of 2 quarters · filed 2021-11-09 | $166.00K 10-Q · filed 2021-11-09 | |||||
| 2020-06-30 | $416.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $662.00K 10-Q · filed 2021-08-09 | ||||||
| 2020-03-31 | $246.00K 10-Q · filed 2021-05-07 | |||||||
| 2019-12-31 | $1.24M 10-K · filed 2022-03-01 | |||||||
| 2019-06-30 | -$68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $105.00K 10-Q · filed 2020-08-10 | $283.00K derived: sum of 3 quarters · filed 2021-03-16 | -$399.00K derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2019-03-31 | $173.00K 10-Q · filed 2020-05-11 | $351.00K derived: sum of 2 quarters · filed 2021-03-16 | -$331.00K derived: sum of 3 quarters · filed 2021-03-16 | $190.00K derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$504.00K derived: sum of 2 quarters · filed 2021-03-16 | $17.00K derived: sum of 3 quarters · filed 2021-03-16 | $300.00K 10-K · filed 2021-03-16 | $299.64K 10-K · filed 2019-03-18 | |||
| 2018-09-30 | -$682.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$161.00K derived: sum of 2 quarters · filed 2019-11-07 | $122.00K 10-Q · filed 2019-11-07 | $122.04K 10-Q · filed 2018-11-07 | $867.80K derived: sum of 4 quarters · filed 2020-03-16 | |||
| 2018-06-30 | $521.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $804.00K 10-Q · filed 2019-08-09 | $804.06K 10-Q · filed 2018-08-09 | $1.55M derived: sum of 3 quarters · filed 2020-03-16 | $1.42M derived: sum of 4 quarters · filed 2020-03-16 | |||
| 2018-03-31 | $283.00K 10-Q · filed 2019-05-10 | $283.08K 10-Q · filed 2018-05-10 | $1.03M derived: sum of 2 quarters · filed 2020-03-16 | $895.19K derived: sum of 3 quarters · filed 2020-03-16 | $787.28K derived: sum of 4 quarters · filed 2020-03-16 | |||
| 2017-12-31 | $745.80K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $612.19K derived: sum of 2 quarters · filed 2020-03-16 | $504.28K derived: sum of 3 quarters · filed 2020-03-16 | $968.00K 10-K · filed 2020-03-16 | $968.40K 10-K · filed 2018-03-16 | |||
| 2017-09-30 | -$133.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$241.52K derived: sum of 2 quarters · filed 2018-11-07 | $222.20K 10-Q · filed 2018-11-07 | -$82.43K derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-06-30 | -$107.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $355.81K 10-Q · filed 2018-08-09 | $51.18K derived: sum of 3 quarters · filed 2019-03-18 | $989.06K derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | $463.72K 10-Q · filed 2018-05-10 | $159.08K derived: sum of 2 quarters · filed 2019-03-18 | $1.10M derived: sum of 3 quarters · filed 2019-03-18 | $826.14K derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | -$304.63K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $633.25K derived: sum of 2 quarters · filed 2019-03-18 | $362.42K derived: sum of 3 quarters · filed 2019-03-18 | $695.47K 10-K · filed 2019-03-18 | ||||
| 2016-09-30 | $937.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $667.06K derived: sum of 2 quarters · filed 2017-11-07 | $1.00M 10-Q · filed 2017-11-07 | $993.44K derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | -$270.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $62.22K 10-Q · filed 2017-08-07 | $55.56K derived: sum of 3 quarters · filed 2018-03-16 | $63.31K derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $333.05K 10-Q · filed 2017-05-04 | $326.39K derived: sum of 2 quarters · filed 2018-03-16 | $334.14K derived: sum of 3 quarters · filed 2018-03-16 | $438.29K derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | -$6.66K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $1.09K derived: sum of 2 quarters · filed 2018-03-16 | $105.25K derived: sum of 3 quarters · filed 2018-03-16 | $105.25K 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $7.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $111.90K derived: sum of 2 quarters · filed 2016-11-09 | $111.90K 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | $104.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $104.15K 10-Q · filed 2016-08-04 | ||||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 | |||||||
| 2014-09-30 | $292.11K 10-Q · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |